NEW YORK (GenomeWeb News) – Nanosphere today announced that the US Food and Drug Administration has cleared its test for the detection of gram-negative bacteria that cause bloodstream infections.

Additionally, the firm said that it has submitted to FDA its test for gastrointestinal infections and announced preliminary revenues of $3.4 million for the fourth quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.